Table of Contents Author Guidelines Submit a Manuscript
Table of Contents Alerts

To receive news and publication updates for BioMed Research International, enter your email address in the box below.

BioMed Research International
Volume 2014 (2014), Article ID 315494, 9 pages
http://dx.doi.org/10.1155/2014/315494
Review Article

Role of Nutrient-Sensing Signals in the Pathogenesis of Diabetic Nephropathy

Shinji Kume,1 Daisuke Koya,2 Takashi Uzu,1 and Hiroshi Maegawa1

1Department of Medicine, Shiga University of Medical Science, Tsukinowa-Cho, Seta, Otsu, Shiga 520-2192, Japan
2Division of Diabetology & Endocrinology, Kanazawa Medical University, Kahoku-Gun, Ishikawa 920-0265, Japan

Received 25 March 2014; Accepted 13 May 2014; Published 14 July 2014

Academic Editor: Akito Maeshima

Copyright © 2014 Shinji Kume et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Zoncu, A. Efeyan, and D. M. Sabatini, “MTOR: from growth signal integration to cancer, diabetes and ageing,” Nature Reviews Molecular Cell Biology, vol. 12, no. 1, pp. 21–35, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. K. E. Wellen and C. B. Thompson, “Cellular metabolic stress: considering how cells respond to nutrient excess,” Molecular Cell, vol. 40, no. 2, pp. 323–332, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. G. R. Steinberg and B. E. Kemp, “AMPK in health and disease,” Physiological Reviews, vol. 89, no. 3, pp. 1025–1078, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Imai and L. Guarente, “Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases,” Trends in Pharmacological Sciences, vol. 31, no. 5, pp. 212–220, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Guarente, “Sirtuins, aging, and medicine,” The New England Journal of Medicine, vol. 364, no. 23, pp. 2235–2244, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. T. B. Huber, G. Walz, and E. W. Kuehn, “MTOR and rapamycin in the kidney: signaling and therapeutic implications beyond immunosuppression,” Kidney International, vol. 79, no. 5, pp. 502–511, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Hao and V. H. Haase, “Sirtuins and their relevance to the kidney,” Journal of the American Society of Nephrology, vol. 21, no. 10, pp. 1620–1627, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. K. R. Hallows, P. F. Mount, N. M. Pastor-Soler, and D. A. Power, “Role of the energy sensor AMP-activated protein kinase in renal physiology and disease,” The American Journal of Physiology—Renal Physiology, vol. 298, no. 5, pp. F1067–F1077, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Kume, M. C. Thomas, and D. Koya, “Nutrient sensing, autophagy, and diabetic nephropathy,” Diabetes, vol. 61, no. 1, pp. 23–29, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Baltzer, S. K. Tiefenböck, and C. Frei, “Mitochondria in response to nutrients and nutrient-sensitive pathways,” Mitochondrion, vol. 10, no. 6, pp. 589–597, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Tanaka, S. Kume, S. Araki et al., “Fenofibrate, a PPARα agonist, has renoprotective effects in mice by enhancing renal lipolysis,” Kidney International, vol. 79, no. 8, pp. 871–882, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. I. Hwang, J. Lee, J. Y. Huh et al., “Catalase deficiency accelerates diabetic renal injury through peroxisomal dysfunction,” Diabetes, vol. 61, no. 3, pp. 728–738, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. M. T. Lindenmeyer, M. P. Rastaldi, M. Ikehata et al., “Proteinuria and hyperglycemia induce endoplasmic reticulum stress,” Journal of the American Society of Nephrology, vol. 19, no. 11, pp. 2225–2236, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. J. M. Forbes, M. T. Coughlan, and M. E. Cooper, “Oxidative stress as a major culprit in kidney disease in diabetes,” Diabetes, vol. 57, no. 6, pp. 1446–1454, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Mizushima and M. Komatsu, “Autophagy: renovation of cells and tissues,” Cell, vol. 147, no. 4, pp. 728–741, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Kume, T. Uzu, K. Horiike et al., “Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney,” Journal of Clinical Investigation, vol. 120, no. 4, pp. 1043–1055, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Kim, M. Kundu, B. Viollet, and K. Guan, “AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1,” Nature Cell Biology, vol. 13, no. 2, pp. 132–141, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. J. K. Chen, G. Thomas, S. C. Kozma, and R. C. Harris, “S6 kinase 1 knockout inhibits uninephrectomy- or diabetes-induced renal hypertrophy,” The American Journal of Physiology—Renal Physiology, vol. 297, no. 3, pp. F585–F593, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Sataranatarajan, M. M. Mariappan, J. L. Myung et al., “Regulation of elongation phase of mRNA translation in diabetic nephropathy: amelioration by rapamycin,” The American Journal of Pathology, vol. 171, no. 6, pp. 1733–1742, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Sakaguchi, M. Isono, K. Isshiki, T. Sugimoto, D. Koya, and A. Kashiwagi, “Inhibition of mTOR signaling with rapamycin attenuates renal hypertrophy in the early diabetic mice,” Biochemical and Biophysical Research Communications, vol. 340, no. 1, pp. 296–301, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Wittmann, C. Daniel, A. Stief, R. Vogelbacher, K. Amann, and C. Hugo, “Long-term treatment of sirolimus but not cyclosporine ameliorates diabetic nephropathy in the rat,” Transplantation, vol. 87, no. 9, pp. 1290–1299, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Mori, K. Inoki, K. Masutani et al., “The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential,” Biochemical and Biophysical Research Communications, vol. 384, no. 4, pp. 471–475, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Yang, J. Wang, L. Qin et al., “Rapamycin prevents early steps of the development of diabetic nephropathy in rats,” American Journal of Nephrology, vol. 27, no. 5, pp. 495–502, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Lloberas, J. M. Cruzado, M. Franquesa et al., “Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats,” Journal of the American Society of Nephrology, vol. 17, no. 5, pp. 1395–1404, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Nagai, T. Matsubara, A. Mima et al., “Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy,” Kidney International, vol. 68, no. 2, pp. 552–561, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Yamahara, S. Kume, D. Koya et al., “Obesity-mediated autophagy insufficiency exacerbates proteinuria-induced tubulointerstitial lesions,” Journal of the American Society of Nephrology, vol. 24, no. 11, pp. 1769–1781, 2013. View at Google Scholar
  27. K. Inoki, H. Mori, J. Wang et al., “mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice,” Journal of Clinical Investigation, vol. 121, no. 6, pp. 2181–2196, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Godel, B. Hartleben, N. Herbach et al., “Role of mTOR in podocyte function and diabetic nephropathy in humans and mice,” Journal of Clinical Investigation, vol. 121, no. 6, pp. 2197–2209, 2011. View at Publisher · View at Google Scholar
  29. C. Velagapudi, B. S. Bhandari, S. Abboud-Werner, S. Simone, H. E. Abboud, and S. L. Habib, “The tuberin/mTOR pathway promotes apoptosis of tubular epithelial cells in diabetes,” Journal of the American Society of Nephrology, vol. 22, no. 2, pp. 262–273, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Cravedi, P. Ruggenenti, and G. Remuzzi, “Sirolimus for calcineurin inhibitors in organ transplantation: contra,” Kidney International, vol. 78, no. 11, pp. 1068–1074, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Yamauchi, J. Kamon, Y. Minokoshi et al., “Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase,” Nature Medicine, vol. 8, no. 11, pp. 1288–1295, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. P. G. Cammisotto, I. Londono, D. Gingras, and M. Bendayan, “Control of glycogen synthase through ADIPOR1-AMPK pathway in renal distal tubules of normal and diabetic rats,” The American Journal of Physiology—Renal Physiology, vol. 294, no. 4, pp. F881–F889, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. Z. Guo and Z. Zhao, “Effect of N-acetylcysteine on plasma adiponectin and renal adiponectin receptors in streptozotocin-induced diabetic rats,” European Journal of Pharmacology, vol. 558, no. 1–3, pp. 208–213, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Lee, D. Feliers, M. M. Mariappan et al., “A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy,” American Journal of Physiology: Renal Physiology, vol. 292, no. 2, pp. F617–F627, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Kitada, S. Kume, N. Imaizumi, and D. Koya, “Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1- independent pathway,” Diabetes, vol. 60, no. 2, pp. 634–643, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Kume, T. Uzu, S. Araki et al., “Role of altered renal lipid metabolism in the development of renal injury induced by a high-fat diet,” Journal of the American Society of Nephrology, vol. 18, no. 10, pp. 2715–2723, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. L. L. Dugan, Y. H. You, S. S. Ali et al., “AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function,” Journal of Clinical Investigation, vol. 123, no. 11, pp. 4888–4899, 2013. View at Publisher · View at Google Scholar
  38. K. Sharma, S. RamachandraRao, G. Qiu et al., “Adiponectin regulates albuminuria and podocyte function in mice,” Journal of Clinical Investigation, vol. 118, no. 5, pp. 1645–1656, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. P. G. Cammisotto and M. Bendayan, “Adiponectin stimulates phosphorylation of AMP-activated protein kinase α in renal glomeruli,” Journal of Molecular Histology, vol. 39, no. 6, pp. 579–584, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Tikoo, K. Singh, D. Kabra, V. Sharma, and A. Gaikwad, “Change in histone H3 phosphorylation, MAP kinase p38, SIR 2 and p53 expression by resveratrol in preventing streptozotocin induced type I diabetic nephropathy,” Free Radical Research, vol. 42, no. 4, pp. 397–404, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. C. Li, F. Cai, Y. Yang et al., “Tetrahydroxystilbene glucoside ameliorates diabetic nephropathy in rats: involvement of SIRT1 and TGF-β1 pathway,” European Journal of Pharmacology, vol. 649, no. 1–3, pp. 382–389, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. H. Y. Cohen, C. Miller, K. J. Bitterman et al., “Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase,” Science, vol. 305, no. 5682, pp. 390–392, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. K. Hasegawa, S. Wakino, P. Simic et al., “Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes,” Nature Medicine, vol. 19, no. 11, pp. 1496–1504, 2013. View at Publisher · View at Google Scholar
  44. W. He, Y. Wang, M. Zhang et al., “Sirt1 activation protects the mouse renal medulla from oxidative injury,” Journal of Clinical Investigation, vol. 120, no. 4, pp. 1056–1068, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. K. Hasegawa, S. Wakino, K. Yoshioka et al., “Kidney-specific overexpression of Sirt1 protects against acute kidney injury by retaining peroxisome function,” Journal of Biological Chemistry, vol. 285, no. 17, pp. 13045–13056, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Li, X. Qu, S. D. Ricardo, J. F. Bertram, and D. J. Nikolic-Paterson, “Resveratrol inhibits renal fibrosis in the obstructed kidney: potential role in deacetylation of Smad3,” The American Journal of Pathology, vol. 177, no. 3, pp. 1065–1071, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Kume, M. Haneda, K. Kanasaki et al., “Silent information regulator 2 (SIRT1) attenuates oxidative stress-induced mesangial cell apoptosis via p53 deacetylation,” Free Radical Biology & Medicine, vol. 40, no. 12, pp. 2175–2182, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Kume, M. Haneda, K. Kanasaki et al., “SIRT1 inhibits transforming growth factor β-induced apoptosis in glomerular mesangial cells via Smad7 deacetylation,” Journal of Biological Chemistry, vol. 282, no. 1, pp. 151–158, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. J. A. Funk, S. Odejinmi, and R. G. Schnellmann, “SRT1720 induces mitochondrial biogenesis and rescues mitochondrial function after oxidant injury in renal proximal tubule cells,” Journal of Pharmacology and Experimental Therapeutics, vol. 333, no. 2, pp. 593–601, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. S.-J. Lin, P.-A. Defossez, and L. Guarente, “Requirement of NAD and SIR2 for life-span extension by calorie restriction in saccharomyces cerevisiae,” Science, vol. 289, no. 5487, pp. 2126–2128, 2000. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Kitada, A. Takeda, T. Nagai, H. Ito, K. Kanasaki, and D. Koya, “Dietary restriction ameliorates diabetic nephropathy through anti-inflammatory effects and regulation of the autophagy via restoration of sirt1 in diabetic wistar fatty (fa/fa) rats: a model of type 2 diabetes,” Experimental Diabetes Research, vol. 2011, Article ID 908185, 11 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Sieber, M. T. Lindenmeyer, K. Kampe et al., “Regulation of podocyte survival and endoplasmic reticulum stress by fatty acids,” The American Journal of Physiology—Renal Physiology, vol. 299, no. 4, pp. F821–F829, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. A. V. Cybulsky, “Endoplasmic reticulum stressin proteinuric kidney disease,” Kidney International, vol. 77, no. 3, pp. 187–193, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. G. Kroemer, G. Mariño, and B. Levine, “Autophagy and the integrated stress response,” Molecular Cell, vol. 40, no. 2, pp. 280–293, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. I. H. Lee, L. Cao, R. Mostoslavsky et al., “A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 9, pp. 3374–3379, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. J. Farré, R. Manjithaya, R. D. Mathewson, and S. Subramani, “PpAtg30 tags peroxisomes for turnover by selective autophagy,” Developmental cell, vol. 14, no. 3, pp. 365–376, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. B. Hartleben, M. Gödel, C. Meyer-Schwesinger et al., “Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice,” Journal of Clinical Investigation, vol. 120, no. 4, pp. 1084–1096, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. T. Kimura, Y. Takabatake, A. Takahashi et al., “Autophagy protects the proximal tubule from degeneration and acute ischemic injury,” Journal of the American Society of Nephrology, vol. 22, no. 5, pp. 902–913, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. M. Jiang, K. Liu, J. Luo, and Z. Dong, “Autophagy is a renoprotective mechanism during in vitro hypoxia and in vivo ischemia-reperfusion injury,” American Journal of Pathology, vol. 176, no. 3, pp. 1181–1192, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Periyasamy-Thandavan, M. Jiang, Q. Wei, R. Smith, X. Yin, and Z. Dong, “Autophagy is cytoprotective during cisplatin injury of renal proximal tubular cells,” Kidney International, vol. 74, no. 5, pp. 631–640, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. A. Takahashi, T. Kimura, Y. Takabatake et al., “Autophagy guards against cisplatin-induced acute kidney injury,” The American Journal of Pathology, vol. 180, no. 2, pp. 517–525, 2012. View at Publisher · View at Google Scholar · View at Scopus
  62. K. L. Stanhope, J. M. Schwarz, N. L. Keim et al., “Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans,” Journal of Clinical Investigation, vol. 119, no. 5, pp. 1322–1334, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. T. J. Wang, M. G. Larson, R. S. Vasan et al., “Metabolite profiles and the risk of developing diabetes,” Nature Medicine, vol. 17, no. 4, pp. 448–453, 2011. View at Google Scholar
  64. E. P. Rhee, S. Cheng, M. G. Larson et al., “Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans,” Journal of Clinical Investigation, vol. 121, no. 4, pp. 1402–1411, 2011. View at Publisher · View at Google Scholar · View at Scopus